Sector: Energy | Industry: Uranium |
See Regulatory Filings on SEDAR |
Company Contact | |
Address: | 1100-40 University Ave TORONTO ON M5J 1T1 |
Tel: | N/A |
Website: | www.uraniumparticipation.com |
IR: | See website |
Key People | ||
Jeff Kennedy Independent Chairman of the Board | David Daniel Cates President, Chief Executive Officer | Gabriel McDonald Chief Financial Officer |
Timothy Stephen Gabruch Chief Commercial Officer | Amanda Willett Corporate Secretary |
Business Overview |
Uranium Participation Corporation invests substantially all of its assets in uranium oxide in concentrates (U3O8) and uranium hexafluoride (UF6) (collectively uranium), with the primary investment objective of achieving appreciation in the value of its uranium holdings through increases in the uranium price. The Company's strategy is to invest in holdings of uranium and not to actively speculate on changes in uranium prices by entering into exchange and investment contracts or derivative arrangements. The uranium owned is stored at uranium conversion or facilities owned by different organizations in Canada, France and the United States. It also lends its uranium to third parties from time to time. The Company invests approximately 85% of the proceeds of its equity offerings in uranium. The Company's uranium is held directly by the Company or indirectly through its subsidiary, Uranium Participation Bermuda Limited. Denison Mines Inc. is the Company's investment the manager. |
Financial Overview |
For the nine months ended 30 November 2020, UraniumParticipation Corp revenues increased from -C$28.3M toC$88.3M. Net income totaled C$83.6M vs. loss of C$32.5M.Revenues reflect Unrealized (losses) gains on investmentincrease from -C$35.2M to C$83.1M, Income from lendingand/or relocation of increase from C$437K to C$1.5M. NetIncome reflects Legal and Other Professional Fees decreaseof 73% to C$80K (expense). |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $575.73M as of Nov 30, 2020 |
Annual revenue (TTM): | $64.11M as of Nov 30, 2020 |
EBITDA (TTM): | $57.55M as of Nov 30, 2020 |
Net annual income (TTM): | $57.38M as of Nov 30, 2020 |
Free cash flow (TTM): | -$4.46M as of Nov 30, 2020 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 134,939,651 as of Jan 18, 2021 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |